1: Shi J, et al. Correlation of CD44v6 expression with ovarian cancer progression and recurrence. BMC Cancer. 2013 Apr 8;13:182.

2: Wei X, et al. Hyaluronic Acid-Based Nanogel-Drug Conjugates with Enhanced Anticancer Activity Designed for the Targeting of CD44-Positive and Drug-Resistant Tumors. Bioconjug Chem. 2013 Apr 17;24(4):658-68.

3: Ganesh S, et al. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors. Biomaterials. 2013 Apr;34(13):3489-502.

4: Nolan MJ, et al. sCD44 internalization in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2013 Jan 17;54(1):592-601.

5: Franzmann EJ, et al. Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma. Head Neck. 2012 May;34(5):687-95.

6: Päll T, et al. Soluble CD44 interacts with intermediate filament protein vimentin on endothelial cell surface. PLoS One. 2011;6(12):e29305